Skip to main content

Table 1 Summary of association results of the genome-wide association study

From: A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients

    

  ADRb

  Non-ADRc

RAF

Pvalue

  

CHR

SNP

Gene

Allele 1/2 (risk)

11

12

22

11

12

22

ADR

Non-ADR

Allelic

Dominant

Recessive

ORa

95% CI

2

rs3820706

CACNB4

A/G (G)

18

169

116

167

421

291

0.66

0.57

8.26E-05

1.07E-01

8.13E-09

3.71

(2.24-6.15)

2

rs6725180

CACNB4

A/C (C)

17

152

134

135

429

316

0.69

0.60

7.90E-05

1.11E-02

3.84E-06

3.05

(1.81-5.14)

8

rs16908658

FAM135B

G/A (G)

30

93

180

23

286

571

0.25

0.19

1.07E-03

9.68E-02

9.93E-07

4.09

(2.34-7.17)

10

rs7476422

PCDH15

T/G (G)

4

47

252

34

245

601

0.91

0.82

1.20E-07

3.77E-07

3.58E-02

2.17

(1.60-2.93)

10

rs857373

PCDH15

G/A (A)

5

55

243

43

255

581

0.89

0.81

5.16E-07

3.15E-06

1.11E-02

2.00

(1.51-2.66)

10

rs857392

PCDH15

G/A (A)

5

55

243

42

252

584

0.89

0.81

9.08E-07

5.95E-06

1.60E-02

1.97

(1.48-2.62)

10

rs1319836

PCDH15

C/T (T)

5

55

243

42

254

583

0.89

0.81

9.10E-07

4.34E-06

1.60E-02

1.98

(1.49-2.63)

10

rs7919725

PCDH15

A/G (G)

5

56

242

42

256

580

0.89

0.81

9.94E-07

4.68E-06

1.60E-02

1.97

(1.48-2.60)

10

rs857369

PCDH15

T/C (C)

1

32

270

18

178

684

0.94

0.88

2.29E-06

7.25E-06

5.87E-02

2.33

(1.60-3.39)

10

rs9416306

PCDH15

G/T (T)

1

32

270

18

178

682

0.94

0.88

2.29E-06

7.13E-06

5.88E-02

2.34

(1.61-3.39)

10

rs1219862

PCDH15

C/T (T)

2

31

270

17

182

681

0.94

0.88

2.73E-06

5.08E-06

1.85E-01

2.28

(1.58-3.30)

13

rs7318267

FARP1

C/T (T)

11

149

143

108

387

385

0.72

0.66

6.69E-03

3.15E-01

4.09E-06

3.71

(1.97-7.01)

13

rs2282048

FARP1

T/C (C)

11

148

144

107

387

386

0.72

0.66

5.72E-03

2.84E-01

6.24E-06

3.68

(1.95-6.93)

17

rs1530357

LOC100506974

A/G (A)

57

170

76

114

417

349

0.47

0.37

1.11E-05

4.29E-06

1.39E-02

1.96

(1.45-2.63)

17

rs1530361

LOC100506974

A/G (A)

53

165

85

99

408

372

0.45

0.35

8.83E-06

1.12E-05

7.04E-03

1.54

(1.27-1.86)

19

rs11666971

LASS4

G/A (G)

46

119

138

56

379

445

0.35

0.28

1.64E-03

1.43E-01

8.13E-06

2.63

(1.74-3.96)

  1. aORs and CIs are calculated according to the associated genetic model; bindividuals who developed grade 2 alopecia; cindividuals who did not developed any ADRs after chemotherapy. CHR, chromosome; SNP, single nucleotide polymorphism; ADR, adverse drug reaction; RAF, risk allele frequency; OR, odds ratio; CI, confidence interval.